Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours

Autor: Bennouna, J. *, Fumoleau, P., Armand, J.-P., Raymond, E., Campone, M., Delgado, F.-M., Puozzo, C., Marty, M.
Zdroj: In Annals of Oncology April 2003 14(4):630-637
Databáze: ScienceDirect